HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia.

Abstract
Autologous cell implantation and angiogenic gene therapy have been evaluated in critical limb ischemic patients. Here, we compared the features of these strategies individually and in combination. C57BL/6J mice with ischemic hindlimbs were injected with adherent mononuclear cells (aMNCs) from bone marrow or adenovirus encoding the hepatocyte growth factor (HGF) gene (Ad-HGF). Under comparable angiogenic conditions, 10 x 10(5) aMNCs produced significantly higher amounts of VEGF and FGF-2 and stimulated the number of arterioles in ischemic muscle compared with 1 x 10(8) plaque-forming units (pfu) of Ad-HGF. Ad-HGF produced 10 times more HGF in ischemic muscle compared with aMNCs. Injection of 0.3 x 10(5) aMNCs previously transfected with Ad-HGF (aMNC/Ad-HGF) increased blood flow and elevated the numbers of capillaries and arterioles to levels comparable with that seen with 10 x 10(5) aMNCs or 1 x 10(8) pfu of Ad-HGF. Hypoxic conditions induced the apoptotic death of aMNCs. However, coincubation with HGF or aMNC/Ad-HGF protected cells against apoptosis. HGF stimulated the migration of aMNCs, and the migration capacity of the aMNC/Ad-HGF group was significantly higher than that in the aMNC/Ad-LacZ group. In conclusion, cell-based HGF gene therapy decreased the number of cells required for neovascularization. This strategy can be an effective angiogenic therapy.
AuthorsYasutaka Yamamoto, Takashi Matsuura, Genta Narazaki, Miyoko Sugitani, Kohei Tanaka, Akihiro Maeda, Goshi Shiota, Kenzo Sato, Akio Yoshida, Ichiro Hisatome
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 297 Issue 4 Pg. H1329-36 (Oct 2009) ISSN: 1522-1539 [Electronic] United States
PMID19666845 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • Fibroblast Growth Factor 2
  • Hepatocyte Growth Factor
Topics
  • Adenoviridae (genetics)
  • Animals
  • Apoptosis
  • Bone Marrow Transplantation
  • Cell Hypoxia
  • Cell Movement
  • Cells, Cultured
  • Combined Modality Therapy
  • Disease Models, Animal
  • Fibroblast Growth Factor 2 (metabolism)
  • Genetic Therapy (methods)
  • Genetic Vectors
  • Hepatocyte Growth Factor (biosynthesis, genetics)
  • Hindlimb
  • Ischemia (genetics, metabolism, physiopathology, therapy)
  • Leukocytes, Mononuclear (metabolism, pathology, transplantation)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal (blood supply)
  • Neovascularization, Physiologic
  • Recovery of Function
  • Regional Blood Flow
  • Time Factors
  • Transfection
  • Transplantation, Autologous
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: